🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 IACH 𝘛𝘳𝘢𝘯𝘴𝘱𝘭𝘢𝘯𝘵 𝘈𝘤𝘢𝘥𝘦𝘮𝘺 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝗽𝗼𝘀𝘁 𝗔𝗦𝗖𝗢/𝗘𝗛𝗔 𝟮𝟬𝟮𝟱 𝗿𝗼𝘂𝗻𝗱𝘁𝗮𝗯𝗹𝗲 𝘁𝗮𝗯𝗹𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗦𝘁𝗲𝗺 𝗖𝗲𝗹𝗹 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁

Few things feel as good as finally hitting ‘submit’ on your abstract after all the effort. 🤙 Now, fingers crossed!

Watch our expert steering committee discuss the use of ECP + ruxolitinib to prevent cGvHD in patients with SR-aGvHD, in response to a presentation from guest speaker Nico Gagelmann: loom.ly/4tkgPLA #GvHD #MedNews #MedEd

Quality over quantity of life!! Out in Journal of Clinical Oncology a prospective trial finding early palliative care during stem cell transplant isn’t just supportive... it’s transformative!! Better quality of life, less depression, mental health benefits lasting up to 6 months after treatment.

The EBMT Trainee Committee Esra Gülderen Nico Gagelmann Alex Rampotas Claire Horgan Carmelo Gurnari 💡 Discover more and apply to become a member of the EBMT Trainee Committee ⬇️ ebmt.org/ebmt/news/appl…

Excellent opportunity for discussion with 🌍 colleagues on the difficult topic of defining suboptimal responders to JAKi in the contemporary era! A moving target 🎯…. #MPNsm VJHemOnc #iwMPN25 Nicola Polverelli, MD, PhD Prithviraj Bose Beth Psaila Claire Harrison Dr Deepti Radia

Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 Finally, awake after a long REMS slumber!!! ASTCT astctjournal.org/article/S2666-…

Watch a discussion by our steering committee on the use of ECP + ruxolitinib combination, including key efficacy outcomes, in patients with SR-aGvHD: loom.ly/4tkgPLA #GvHD #MedNews #MedEd

AI revolution in MDS: Adrián Mosquera Orgueira on classification and risk stratification VJHemOnc #iwMDS25 #iwMPN25 #AI #MDS #MachineLearning

ASCO® 2025 Insights: Reduced Dose PTCy in Patients With AML Receiving MUD Allogeneic HSCT | VuMedi vumedi.com/video/ascor-20… via @vumedi

International Consortium for MDS (icMDS) what an amazing discussion this morning on therapy of #MDS Amer Zeidan MBBS,MHS ‏عامر زيدان Yazan Madanat, MD VJHemOnc striving for a better future for our patients

It’s always great to listen to Carmelo Gurnari when it comes to MDS 🔬

Looking for the best #HCT & #CT course? ✅ EBMT exam prep ✅ latest updates in adult, paeds, nursing ✅ Translational &basic science ✅ diverse topics ✅ networking ✅ connect with the EBMT Trainee Committee! 📝 Submit your case, apply for travel grants! ebmt.org/events/10th-in…

Great course to reviews on the EBMT exam - best placed for haematologists late in their training or early in their careers as attending

A 40 year old man, 2 years post kidney transplant presents with a persistent headache 😭 Imaging is unremarkable. CSF 👇🏽 What do you see? Diagnosis? Management? #MedTwitter

Top 10 Heme-Onc Oncologists for June 2025, curated by LARVOL CLIN. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Hematology #Oncology #CancerResearch #CancerData #OncologyInsights | Fadi Haddad, MD |

👉👉👉Delighted to share our new collaborative article in Leukemia Journal led by 🚨 Mrinal Patnaik & Guillermo Montalban-Bravo & Eric Padron MD | Sanam Loghavi, MD صنم لغوی 🔬🧬 Rashmi Kanagal-Shamanna, MD Naveen Pemmaraju, MD Rami komrokji Naseema Gangat nature.com/articles/s4137… | #leusm #TET2

Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR Transplantation and Cellular Therapy Journal astctjournal.org/article/S2666-…

I Became a Doctor not Because I Want to Help Others… - Nico Gagelmann Nico Gagelmann oncodaily.com/blog/nico-gage… #Cancer #Medicine #Health #Healthcare #Oncology #MedX #MedNews #MedEd #OncoDaily

In REACH3, ruxolitinib vastly improved failure-free survival (38.4 vs 5.7 months) over best therapy in steroid-refractory chronic GVHD, with durable responses and no new safety issues over 3 years. Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…